Clovis Oncology reported $32.92M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Acorda Therapeutics ACOR:US $ 32.37M 100K
Agenus AGEN:US $ 16.65M 298K
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Anika Therapeutics ANIK:US $ 17.99M 186K
Arrowhead Research ARWR:US $ 17.86M 1.67M
Astrazeneca AZN:US 2.57B 76M
AstraZeneca AZN:LN 2.57B 76M
Cerulean Pharma CERU:US $ 1.82M 142.69K
Clovis Oncology CLVS:US $ 32.92M 2.98M
Eli Lilly And LLY:US $ 1.69B 109.7M
Enanta Pharmaceuticals ENTA:US $ 8.48M 151K
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
GlaxoSmithKline GSK:LN 2.5B 183M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Insmed INSM:US $ 57.18M 5.63M
Intrexon XON:US $ 20M 1.3M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Rigel Pharmaceuticals RIGL:US $ 22.38M 257K
Sangamo Biosciences SGMO:US $ 16.49M 338K
Seattle Genetics SGEN:US $ 165.13M 5.29M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Veracyte VCYT:US $ 19.91M 639K
YTE INCY:US $ 168.86M 15.06M